Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
about
Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Pharmacokinetics of a novel ex ...... m two phase 3 clinical trials.
@en
type
label
Pharmacokinetics of a novel ex ...... m two phase 3 clinical trials.
@en
prefLabel
Pharmacokinetics of a novel ex ...... m two phase 3 clinical trials.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Pharmacokinetics of a novel ex ...... om two phase 3 clinical trials
@en
P2093
E Santagostino
F Abdul-Karim
J Oldenburg
T Matsushita
W H O Clausen
P2860
P304
P356
10.1111/HAE.13191
P577
2017-02-24T00:00:00Z